Pladienolide D Synthesis Route for High-Purity Crystallization
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for producing pladienolide D, a macrolide-based compound with antitumor activity, face challenges in achieving high purity and scalability due to difficulties in purification and limited production amounts, particularly in fermentation and chemical synthesis.
Innovation Solution
A method involving the reaction of specific compounds in the presence of a metal catalyst, followed by protecting group removal and optional solvate conversion, to produce pladienolide D with high yield and purity, suitable for scaled-up production.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If fermentation production using Streptomyces sp. Mer-11107 is used, then pladienolide D can be produced, but purification is difficult and production amount is limited
Solution Approach 1:
The patent changes the production method from fermentation to chemical synthesis, fundamentally altering the production parameters. The chemical synthesis route enables precise control over reaction conditions, stoichiometry, and purification steps, achieving both high yield (suitable for mass production) and high purity (over 99% by HPLC) simultaneously
2Productivity
If chemical total synthesis is used, then pladienolide D can be produced, but further improvement of production method is desired for mass synthesis
Solution Approach 1:
The patent segments the synthesis into distinct, optimized steps: Step 1 forms the core macrolide structure through cross-coupling reactions with high efficiency, Step 2 introduces necessary functional groups, and Step 3 performs final deprotection. Each step is designed for scalability and can be independently optimized, enabling mass synthesis while maintaining high overall yield
Solution Approach 2:
The patent optimizes reaction parameters including catalyst selection (palladium-based catalysts), solvent systems, temperature profiles, and stoichiometry to maximize yield at each step. These parameter optimizations collectively enable the process to scale from laboratory to industrial production levels
3Manufacturing precision
If silica gel column purification is used, then pladienolide D can be purified, but the process becomes complex and less suitable for mass production
Solution Approach 1:
The patent employs crystallization as the primary purification method, utilizing phase transition from dissolved state to crystalline solid. This approach replaces complex chromatographic separations with a simpler, scalable crystallization process that achieves high purity (>99% by HPLC) and is readily adaptable to mass production
Solution Approach 2:
The patent extracts the target compound from the reaction mixture through crystallization, separating pladienolide D from impurities based on differences in solubility and crystal lattice formation. This extraction method is simpler and more scalable than silica gel column chromatography
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method enables the production of high-quality pladienolide D with good reproducibility, allowing for purification by crystallization and achieving high purity, thus addressing the limitations of previous methods.
Implementation Method 1
allowing a compound represented by formula (A1) to react with a compound represented by formula (B1) in the presence of a metal catalyst to obtain a compound represented by formula (C1)
Data Source
AI summary
Disclosed are a method for producing pladienolide D that includes a step that reacts a compound represented by formula (A1) with a compound represented by formula (B1) in the presence of a metal catalyst to obtain a compound represented by formula (C1) (in the formulas, X means hydrogen, optionally substituted boryl, optionally substituted stannyl, or optionally substituted silyl, R4 is hydrogen, etc., R5 is optionally substituted benzoyl, etc., and R1 and R2 each independently are hydrogen, etc.) and crystals of a solvate of pladienolide D.